tiprankstipranks
Trending News
More News >
Pliant Therapeutics, Inc. (PLRX)
:PLRX
US Market

Pliant Therapeutics (PLRX) Income Statement

Compare
502 Followers

Pliant Therapeutics Income Statement

Last quarter (Q4 2024), Pliant Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Pliant Therapeutics's net income was $-49.73M. See Pliant Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.58M$ 9.69M$ 7.57M$ 41.82M
Gross Profit
$ 0.00$ 1.58M$ 6.00M$ 4.37M$ 41.82M
Operating Expenses
$ 228.37M$ 185.72M$ 136.88M$ 27.56M$ 83.46M
Depreciation and Amortization
$ 0.00$ 1.84M$ 3.68M$ 3.20M$ 1.31M
EBITDA
$ -228.37M$ -158.23M$ -118.85M$ -95.73M$ -40.34M
Operating Income
$ -228.37M$ -184.15M$ -127.20M$ -19.99M$ -41.65M
Other Income/Expenses
$ 18.06M$ 22.81M$ 3.88M$ 272.00K$ 112.00K
Pretax Income
$ -210.30M$ -161.34M$ -123.32M$ -19.71M$ -41.53M
Net Income
$ -210.30M$ -161.34M$ -121.50M$ -17.91M$ -39.74M
Per Share Metrics
Basic EPS
$ -3.47$ -2.75$ -2.89$ -0.50$ -1.12
Diluted EPS
$ -3.47$ -2.75$ -2.89$ -0.50$ -1.12
Weighted Average Shares Outstanding
60.54M 58.72M 42.02M 35.85M 35.55M
Weighted Average Shares Outstanding (Diluted)
60.54M 58.72M 42.02M 35.85M 35.55M
Currency in USD

Pliant Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis